Detalhe da pesquisa
1.
JAK2 and MPL protein levels determine TPO-induced megakaryocyte proliferation vs differentiation.
Blood
; 124(13): 2104-15, 2014 Sep 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-25143485
2.
Thrombopoietin receptor down-modulation by JAK2 V617F: restoration of receptor levels by inhibitors of pathologic JAK2 signaling and of proteasomes.
Blood
; 119(20): 4625-35, 2012 May 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-22378845
3.
A senescence-like cell-cycle arrest occurs during megakaryocytic maturation: implications for physiological and pathological megakaryocytic proliferation.
PLoS Biol
; 8(9)2010 Sep 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-20838657
4.
[Megakaryopoiesis: regulation of platelet production by thrombopoietin]. / Mégacaryopoïèse: régulation de la production plaquettaire par la thrombopoïétine.
Bull Acad Natl Med
; 197(2): 395-406, 2013 Feb.
Artigo
em Francês
| MEDLINE | ID: mdl-24919369
5.
CXCL12/CXCR4 pathway is activated by oncogenic JAK2 in a PI3K-dependent manner.
Oncotarget
; 8(33): 54082-54095, 2017 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28903325
6.
Evidence for MPL W515L/K mutations in hematopoietic stem cells in primitive myelofibrosis.
Blood
; 110(10): 3735-43, 2007 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-17709604